Literature DB >> 28420869

Verification of oligomycin A structure: synthesis and biological evaluation of 33-dehydrooligomycin A.

Lyudmila N Lysenkova1, Oleg Y Saveljev2, Natalya E Grammatikova1, Vladimir B Tsvetkov3,4,5, Olga B Bekker6, Valery N Danilenko6, Lyubov G Dezhenkova1, Eugene E Bykov1, Olga A Omelchuk1, Alexander M Korolev1, Andrey E Shchekotikhin1,7.   

Abstract

Although, the structure of oligomycin A (1) was confirmed by spectroscopic and chemical evaluations, some crystallographic data cast doubt on the originally adopted structure of the side 2-hydroxypropyl moiety of this antibiotic. It was suggested that the side chain of the oligomycin is enol-related (2-hydroxy-1-propenyl). To clarify this matter we synthesized and evaluated 33-dehydrooligomycin A (2) prepared by the Kornblum oxidation of 33-O-mesyloligomycin A (3) by dimethyl sulfoxide. NMR data for 33-dehydrooligomycin (2) and results of quantum chemical calculations have shown that this derivative exists in the keto rather than in the enol tautomer 2a. The in vitro antimicrobial activity of 2 was approximately two times weaker in comparison with oligomycin A against Streptomyces fradiae ATCC-19609 and reference Candida spp. strains and similar activity against certain filamentous fungi. The docking binding estimate of 2 with FOF1ATP synthase showed a slight decrease in binding affinity for 2 when compared with oligomycin A; that correlated with its activity against S. fradiae ATCC 19609 that is supersensitive to oligomycin A. The in vitro antiproliferative activities of 2 are also discussed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28420869     DOI: 10.1038/ja.2017.48

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  13 in total

1.  Oligomycin, a new antifungal antibiotic.

Authors:  R M SMITH; W H PETERSON; E McCOY
Journal:  Antibiot Chemother (Northfield)       Date:  1954-09

2.  Oligomycins A and C, major secondary metabolites isolated from the newly isolated strain Streptomyces diastaticus.

Authors:  P W Yang; M G Li; J Y Zhao; M Z Zhu; H Shang; J R Li; X L Cui; R Huang; M L Wen
Journal:  Folia Microbiol (Praha)       Date:  2010-03-25       Impact factor: 2.099

3.  Atomic solvation parameters applied to molecular dynamics of proteins in solution.

Authors:  L Wesson; D Eisenberg
Journal:  Protein Sci       Date:  1992-02       Impact factor: 6.725

4.  FoF1-ATP synthase of Streptomyces fradiae ATCC 19609: structural, biochemical, and functional characterization.

Authors:  M G Alekseeva; T A Mironcheva; D A Mavletova; S M Elizarov; N V Zakharevich; V N Danilenko
Journal:  Biochemistry (Mosc)       Date:  2015-03       Impact factor: 2.487

5.  Total synthesis of rutamycin B and oligomycin C.

Authors:  J S Panek; N F Jain
Journal:  J Org Chem       Date:  2001-04-20       Impact factor: 4.354

6.  The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics.

Authors:  Andrey E Shchekotikhin; Valeria A Glazunova; Lyubov G Dezhenkova; Elena K Shevtsova; Valery F Traven'; Jan Balzarini; Hsu-Shan Huang; Alexander A Shtil; Maria N Preobrazhenskaya
Journal:  Eur J Med Chem       Date:  2010-11-19       Impact factor: 6.514

7.  Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements.

Authors:  James J P Stewart
Journal:  J Mol Model       Date:  2007-09-09       Impact factor: 1.810

8.  A comparative study of the single crystal X-ray determination and molecular modelling of the binding of oligomycin to ATP synthase.

Authors:  Roderic C E Green; Alfred E Thumser; David Povey; José W Saldanha; Brian S Potter; Rex A Palmer; Brendan J Howlin
Journal:  Comput Biol Chem       Date:  2009-01-19       Impact factor: 2.877

9.  X-ray structures of two forms of the antibiotic oligomycin A: an inhibitor of ATP synthase.

Authors:  Rex A Palmer; Mark Ladd; Brendan Howlin; David R Lisgarten
Journal:  Future Med Chem       Date:  2013-05       Impact factor: 3.808

10.  Oligomycin frames a common drug-binding site in the ATP synthase.

Authors:  Jindrich Symersky; Daniel Osowski; D Eric Walters; David M Mueller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

View more
  1 in total

Review 1.  Natural products and other inhibitors of F1FO ATP synthase.

Authors:  Bhargav A Patel; Terin L D'Amico; Brian S J Blagg
Journal:  Eur J Med Chem       Date:  2020-09-03       Impact factor: 6.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.